Navigation Links
Easier Treatment for Blood Clot

A pulmonary embolism is a fairly common condition that can be fatal. It is defined as an obstruction of a blood vessel in the lungs, usually due to a blood clot, //which blocks a coronary artery. While treatment is not always successful for a pulmonary embolism, a new study shows a new treatment is just as effective and easier to administer to patients than the current treatment.

According to the American Heart Association, about 600,000 Americans develop a pulmonary embolism annually; 60,000 die from one. The standard treatment for a pulmonary embolism is intravenous heparin requiring the patient to be monitored and hospitalized. Researchers conducted a study to see if a daily injection of the drug fondaparinux would be effective for patients with a pulmonary embolism.

The study included 2,213 patients who had a pulmonary embolism. The patients received either one of three doses of fondaparinux or a continuous intravenous infusion of heparin. Both of the drugs were given for five days. Researchers compared how the patients in each group did after three months and noted if they had a recurrent pulmonary embolism.

Researchers report only 42 of the 1,103 patients on fondaparinux had a recurrent problem compared to 56 of the 1,110 patients on the standard treatment. They also found major bleeding occurred in 1.3 percent of the patients on fondaparinux compared to 1.1 percent of the patients on heparin. The mortality rates after three months were similar in the two groups. About 15 percent of the patients on fondaparinux received the drug on an outpatient basis.

Study authors conclude treatment of pulmonary embolisms with fondaparinux is at least as effective and as safe as the standard treatment. They feel because of the simplicity in giving fondaparinux, it could become the first treatment of choice for many patients with a pulmonary embolism.
'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Easier Dialysis for Kids
3. Easier Methods Required to Screen Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Adopting Easier Methods To Screen Insulin Resistance
6. Easier Tests To Detect Tuberculosis
7. Self Hypnotic Relaxation Makes Breast Biopsy Easier and Less Painful
8. Asthmatic Children Still Not Breathing Easier, Study Says
9. Advances in Treatment of Cataracts
10. Recommendations for Treatment of Blood Pressue
11. Treatment for Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to ... Care Medicine will host industry leaders for the annual spring Convention & Expo, ... the industry adapt to the issues currently affecting urgent care and on-demand healthcare. ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information ... interested persons to bookmark and read organized content on topics such as home care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
Breaking Medicine Technology: